Medindia LOGIN REGISTER
Medindia

Troleandomycin Interaction with other Drugs


Troleandomycin is a macrolide antibiotic, prescribed for different types of bacterial infections, such as tonsillitis, bronchitis, sinusitis, and pneumonia.

Troleandomycin Interaction with 138 drugs. Find out more in the list below:

Acetyl Sulfisoxazole


The metabolism of Troleandomycin can be decreased when combined with Acetyl sulfisoxazole.

Afatinib


The serum concentration of Afatinib can be increased when it is combined with Troleandomycin.

Amiodarone


The metabolism of Troleandomycin can be decreased when combined with Amiodarone.

Advertisement

Amodiaquine


The serum concentration of Amodiaquine can be increased when it is combined with Troleandomycin.

Apalutamide


The serum concentration of Troleandomycin can be decreased when it is combined with Apalutamide.

Aprepitant


The serum concentration of Troleandomycin can be increased when it is combined with Aprepitant.

Advertisement

Artesunate


The serum concentration of the active metabolites of Artesunate can be reduced when Artesunate is used in combination with Troleandomycin resulting in a loss in efficacy.

Asunaprevir


The serum concentration of Asunaprevir can be increased when it is combined with Troleandomycin.

Atazanavir


The metabolism of Troleandomycin can be decreased when combined with Atazanavir.

Advertisement

Atomoxetine


The metabolism of Troleandomycin can be decreased when combined with Atomoxetine.

Atorvastatin


The risk or severity of adverse effects can be increased when Troleandomycin is combined with Atorvastatin.

BCG Vaccine


The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Troleandomycin.

Boceprevir


The metabolism of Troleandomycin can be decreased when combined with Boceprevir.

Bortezomib


The metabolism of Troleandomycin can be decreased when combined with Bortezomib.

Bosentan


The serum concentration of Troleandomycin can be decreased when it is combined with Bosentan.

Bosentan Anhydrous


The serum concentration of Troleandomycin can be decreased when it is combined with Bosentan.

Bosutinib


The serum concentration of Bosutinib can be increased when it is combined with Troleandomycin.

Bosutinib monohydrate


The serum concentration of Bosutinib can be increased when it is combined with Troleandomycin.

Brentuximab Vedotin


The serum concentration of Brentuximab vedotin can be increased when it is combined with Troleandomycin.

Bromocriptine


The risk or severity of adverse effects can be increased when Bromocriptine is combined with Troleandomycin.

Cabergoline


The risk or severity of adverse effects can be increased when Cabergoline is combined with Troleandomycin.

Carbamazepine


The metabolism of Troleandomycin can be increased when combined with Carbamazepine.

Ceritinib


The serum concentration of Troleandomycin can be increased when it is combined with Ceritinib.

Cerivastatin


The serum concentration of Cerivastatin can be increased when it is combined with Troleandomycin.

Cilostazol


The serum concentration of Cilostazol can be increased when it is combined with Troleandomycin.

Clarithromycin


The metabolism of Troleandomycin can be decreased when combined with Clarithromycin.

Clemastine


The metabolism of Troleandomycin can be decreased when combined with Clemastine.

Clotrimazole


The metabolism of Troleandomycin can be decreased when combined with Clotrimazole.

Cobicistat


The metabolism of Troleandomycin can be decreased when combined with Cobicistat.

Colchicine


The serum concentration of Colchicine can be increased when it is combined with Troleandomycin.

Conivaptan


The serum concentration of Conivaptan can be increased when it is combined with Troleandomycin.

Crizotinib


The metabolism of Troleandomycin can be decreased when combined with Crizotinib.

Curcumin


The metabolism of Troleandomycin can be decreased when combined with Curcumin.

Cyclosporine


The metabolism of Troleandomycin can be decreased when combined with Cyclosporine.

Dabigatran Etexilate


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Troleandomycin.

Dabrafenib


The serum concentration of Troleandomycin can be decreased when it is combined with Dabrafenib.

Darunavir


The metabolism of Troleandomycin can be decreased when combined with Darunavir.

Dasatinib


The serum concentration of Troleandomycin can be increased when it is combined with Dasatinib.

Dasatinib Anhydrous


The serum concentration of Troleandomycin can be increased when it is combined with Dasatinib.

Deferasirox


The serum concentration of Troleandomycin can be decreased when it is combined with Deferasirox.

Delavirdine


The metabolism of Troleandomycin can be decreased when combined with Delavirdine.

Dihydroergocornine


The risk or severity of adverse effects can be increased when Dihydroergocornine is combined with Troleandomycin.

Dihydroergocristine


The risk or severity of adverse effects can be increased when Dihydroergocristine is combined with Troleandomycin.

Dihydroergotamine


The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Troleandomycin.

Diltiazem


The metabolism of Troleandomycin can be decreased when combined with Diltiazem.

Doxorubicin


The serum concentration of Doxorubicin can be increased when it is combined with Troleandomycin.

Doxorubicin Hydrochloride


The serum concentration of Doxorubicin can be increased when it is combined with Troleandomycin.

Doxycycline


The metabolism of Troleandomycin can be decreased when combined with Doxycycline.

Doxycycline Anhydrous


The metabolism of Troleandomycin can be decreased when combined with Doxycycline.

Dronedarone


The metabolism of Troleandomycin can be decreased when combined with Dronedarone.

Edoxaban


The serum concentration of Edoxaban can be increased when it is combined with Troleandomycin.

Enzalutamide


The serum concentration of Troleandomycin can be decreased when it is combined with Enzalutamide.

Ergonovine


The risk or severity of adverse effects can be increased when Ergonovine is combined with Troleandomycin.

Ergotamine


The risk or severity of adverse effects can be increased when Ergotamine is combined with Troleandomycin.

Erythromycin


The metabolism of Troleandomycin can be decreased when combined with Erythromycin.

Everolimus


The serum concentration of Everolimus can be increased when it is combined with Troleandomycin.

Fluconazole


The metabolism of Troleandomycin can be decreased when combined with Fluconazole.

Fluvastatin


The serum concentration of Fluvastatin can be increased when it is combined with Troleandomycin.

Fluvoxamine


The metabolism of Troleandomycin can be decreased when combined with Fluvoxamine.

Fosamprenavir


The metabolism of Troleandomycin can be decreased when combined with Fosamprenavir.

Fosaprepitant


The serum concentration of Troleandomycin can be increased when it is combined with Fosaprepitant.

Fosphenytoin


The metabolism of Troleandomycin can be increased when combined with Fosphenytoin.

Fusidate


The serum concentration of Troleandomycin can be increased when it is combined with Fusidic Acid.

Fusidic Acid


The serum concentration of Troleandomycin can be increased when it is combined with Fusidic Acid.

Hypoxis hemerocallidea root extract


The serum concentration of Troleandomycin can be decreased when it is combined with St. John's Wort.

Ibrutinib


The serum concentration of Ibrutinib can be increased when it is combined with Troleandomycin.

Idelalisib


The metabolism of Troleandomycin can be decreased when combined with Idelalisib.

Imatinib


The metabolism of Troleandomycin can be decreased when combined with Imatinib.

Indinavir


The metabolism of Troleandomycin can be decreased when combined with Indinavir.

INDINAVIR ANHYDROUS


The metabolism of Troleandomycin can be decreased when combined with Indinavir.

Isavuconazole


The serum concentration of Troleandomycin can be increased when it is combined with Isavuconazole.

Isavuconazonium


The metabolism of Troleandomycin can be decreased when combined with Isavuconazonium.

Isradipine


The metabolism of Troleandomycin can be decreased when combined with Isradipine.

Itraconazole


The metabolism of Troleandomycin can be decreased when combined with Itraconazole.

Ivacaftor


The serum concentration of Troleandomycin can be increased when it is combined with Ivacaftor.

Ketoconazole


The metabolism of Troleandomycin can be decreased when combined with Ketoconazole.

Ledipasvir


The serum concentration of Ledipasvir can be increased when it is combined with Troleandomycin.

Lisuride


The risk or severity of adverse effects can be increased when Lisuride is combined with Troleandomycin.

Lopinavir


The metabolism of Troleandomycin can be decreased when combined with Lopinavir.

Lovastatin


The serum concentration of Lovastatin can be increased when it is combined with Troleandomycin.

Luliconazole


The serum concentration of Troleandomycin can be increased when it is combined with Luliconazole.

Lumacaftor


The metabolism of Troleandomycin can be increased when combined with Lumacaftor.

Metergoline


The risk or severity of adverse effects can be increased when Metergoline is combined with Troleandomycin.

Methylergonovine


The risk or severity of adverse effects can be increased when Methylergometrine is combined with Troleandomycin.

Methysergide


The risk or severity of adverse effects can be increased when Methysergide is combined with Troleandomycin.

Mifepristone


The serum concentration of Troleandomycin can be increased when it is combined with Mifepristone.

Mitotane


The serum concentration of Troleandomycin can be decreased when it is combined with Mitotane.

Naloxegol


The serum concentration of Naloxegol can be increased when it is combined with Troleandomycin.

Nefazodone


The metabolism of Troleandomycin can be decreased when combined with Nefazodone.

Nelfinavir


The metabolism of Troleandomycin can be decreased when combined with Nelfinavir.

Netupitant


The serum concentration of Troleandomycin can be increased when it is combined with Netupitant.

Nevirapine


The metabolism of Troleandomycin can be increased when combined with Nevirapine.

Nicergoline


The risk or severity of adverse effects can be increased when Nicergoline is combined with Troleandomycin.

Nilotinib


The metabolism of Troleandomycin can be decreased when combined with Nilotinib.

Nintedanib


The serum concentration of Nintedanib can be increased when it is combined with Troleandomycin.

Olaparib


The metabolism of Troleandomycin can be decreased when combined with Olaparib.

Osimertinib


The serum concentration of Troleandomycin can be increased when it is combined with Osimertinib.

Palbociclib


The serum concentration of Troleandomycin can be increased when it is combined with Palbociclib.

Pazopanib


The serum concentration of Pazopanib can be increased when it is combined with Troleandomycin.

Pentobarbital


The metabolism of Troleandomycin can be increased when combined with Pentobarbital.

Pergolide


The risk or severity of adverse effects can be increased when Pergolide is combined with Troleandomycin.

Phenobarbital


The metabolism of Troleandomycin can be increased when combined with Phenobarbital.

Phenytoin


The metabolism of Troleandomycin can be increased when combined with Phenytoin.

Picosulfuric Acid


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Troleandomycin.

Pitavastatin


The serum concentration of Pitavastatin can be increased when it is combined with Troleandomycin.

Posaconazole


The metabolism of Troleandomycin can be decreased when combined with Posaconazole.

Pravastatin


The serum concentration of Pravastatin can be increased when it is combined with Troleandomycin.

Primidone


The metabolism of Troleandomycin can be increased when combined with Primidone.

Ranolazine


The serum concentration of Ranolazine can be increased when it is combined with Troleandomycin.

Rifabutin


The metabolism of Troleandomycin can be increased when combined with Rifabutin.

Rifampin


The metabolism of Troleandomycin can be increased when combined with Rifampicin.

Rifapentine


The metabolism of Troleandomycin can be increased when combined with Rifapentine.

Rifaximin


The serum concentration of Rifaximin can be increased when it is combined with Troleandomycin.

Rilpivirine


The serum concentration of Rilpivirine can be increased when it is combined with Troleandomycin.

Rosuvastatin


The serum concentration of Rosuvastatin can be increased when it is combined with Troleandomycin.

Rucaparib


The metabolism of Troleandomycin can be decreased when combined with Rucaparib.

Saquinavir


The metabolism of Troleandomycin can be decreased when combined with Saquinavir.

Saquinavir Mesylate


The metabolism of Troleandomycin can be decreased when combined with Saquinavir.

Sarilumab


The therapeutic efficacy of Troleandomycin can be decreased when used in combination with Sarilumab.

Sildenafil


The metabolism of Troleandomycin can be decreased when combined with Sildenafil.

Silodosin


The serum concentration of Silodosin can be increased when it is combined with Troleandomycin.

Siltuximab


The serum concentration of Troleandomycin can be decreased when it is combined with Siltuximab.

Simeprevir


The serum concentration of Troleandomycin can be increased when it is combined with Simeprevir.

Simvastatin


The serum concentration of Simvastatin can be increased when it is combined with Troleandomycin.

ST. JOHN'S WORT EXTRACT


The serum concentration of Troleandomycin can be decreased when it is combined with St. John's Wort.

Sulfisoxazole


The metabolism of Troleandomycin can be decreased when combined with Sulfisoxazole.

Telaprevir


The metabolism of Troleandomycin can be decreased when combined with Telaprevir.

Telithromycin


The metabolism of Troleandomycin can be decreased when combined with Telithromycin.

Ticlopidine


The metabolism of Troleandomycin can be decreased when combined with Ticlopidine.

Tocilizumab


The serum concentration of Troleandomycin can be decreased when it is combined with Tocilizumab.

Tolvaptan


The serum concentration of Tolvaptan can be increased when it is combined with Troleandomycin.

Topotecan


The serum concentration of Topotecan can be increased when it is combined with Troleandomycin.

Vemurafenib


The serum concentration of Troleandomycin can be decreased when it is combined with Vemurafenib.

Venlafaxine


The metabolism of Troleandomycin can be decreased when combined with Venlafaxine.

Verapamil


The metabolism of Troleandomycin can be decreased when combined with Verapamil.

Vincristine


The excretion of Vincristine can be decreased when combined with Troleandomycin.

Voriconazole


The metabolism of Troleandomycin can be decreased when combined with Voriconazole.

Ziprasidone


The metabolism of Troleandomycin can be decreased when combined with Ziprasidone.

Advertisement
Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Ultimate Weight Loss Handbook: A Complete Guide to Achieving Your Goals
Stay Connected
Available on the Android Market Available on the App Store

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional